Catalyst Calendar
FDA Calendar
Track key readouts and FDA decision dates in biotech and pharma.
BPW Portfolio
Bio Hedge Fund Shots and more...
Historical FDA Calendar
Review past FDA decisions and clinical readouts.
Market Movers
Track today's biotech market movers
Biotech Earning Calendar
Stay updated on biotech earnings.
Historical PDUFA Dates
Review past PDUFA dates and decisions.
PDUFA Calendar
Stay ahead of upcoming PDUFA dates
Conference Calendar
Keep up with biotech events.
IPO
Upcoming & past IPOs.
Bio Pharma Screener
Catalyst Sync™
Track biotech catalysts.
Hedge Fund Screener
Analyze hedge fund holdings.
Company Screener
Holistic company & pipeline analysis.
All Stocks Holdings
Explore hedge fund stock data.
Heat-Map
Market size & sector heat map.
Inside Trades
Monitor insider trading.
Biotech Analyst Ratings
Biotech analyst ratings & price targets
M&A Tracker
Track M&A deals and acquisition targets
Resources
News
Latest biotech news.
Blogs
Expert market insights.
Modality Leaderboard
Top biotechs by drug modality.
Discord
Join community discussions.
User Guide
Step-by-step platform guide.
Biotech Investing 101
Learn biotech investing.
Pricing

Recent Updates

Recently added Catalysts

Home
News
ZYME

ZYME

5,400,000 Common Shares

Friday, June 8, 2018 1 min read

Key Takeaway: 5,400,000 Common Shares

Full Press Release Details

5,400,000 Common Shares.

Tags: ZYME Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare

Last updated: Jun 8, 2018

Hide

BiopharmaWatch: Your trusted source for comprehensive biotech and pharma market insights, offering advanced tools and real-time data to empower your investment decisions.

Tools
FDA Calendar
PDUFA Calendar
CatalystSync
Company Screener
Hedge Funds

Company
About
Blog
Contact Us
Editorial Policy
User Guide

Legal
Legal
Privacy Policy
Terms of Service
Disclaimer

Newsletter